Anthrax Vaccine Market is Expected to Reach US$ 845.7 Mn by 2025Posted by Shristi on September 26th, 2019 Analyst Speak:
“The Global Anthrax Vaccine Market is expected to reach US$ 845.7 Mn by 2025 owing to growth in R&D for the development of newer products” The global anthrax vaccine market is expected to reach US$ 845.7 Mn by 2025. Anthrax is caused by the bacterium Bacillus anthracis is a deadly human disease that also infects animals like horse, sheep, cattle and goats. The global anthrax vaccines market is driven by increasing prevalence of anthrax disease globally. There is increasing support from the government towards the research and development of new vaccines. They ensure that these vaccines are cost effective so that it reaches even the remote areas of the world. The government and the NGOs are also doing campaigns so spread the awareness in the villages so that people should be updated with the vaccination procedure. Moreover, presence of large target population is also fueling the growth of this global anthrax vaccine market. On the flip side, lack of awareness about the anthrax disease diagnostic test in some regions is hampering the growth of global anthrax vaccine market. Global anthrax vaccine market is segmented on the basis of type, end user, and region. Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=15508
Cell free PA Vaccines Dominate the Global Anthrax Vaccine Market Based on the type of vaccine, global anthrax vaccine market is segmented into cell free PA vaccines and live vaccines. Cell free PA vaccines tend to dominate the global anthrax vaccine market. A cell free filtrate contains antigenic proteins which are adsorbed or precipitated using an aluminium-based adjuvant. The principal active ingredient is the protective antigen (PA) component of the anthrax toxin complex. These vaccines include Anthrax Vaccine Adsorbed (AVA) and Anthrax Vaccine Precipitated (AVP). The components of these vaccines are much more enhanced and thus provide better protection against the disease.
North America Leads the Global Anthrax Vaccine Market
PBI’s global anthrax vaccine market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America anthrax vaccine market dominates the global anthrax vaccine market. In terms of revenue US accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to their advancement in research and development sector, favorable government initiatives, growing population and rise in prevalence of anthrax diseases. However, Europe and Asia Pacific anthrax vaccine market is expected to grow at a good rate over the years due to their rising awareness, improving healthcare infrastructure, raising anthrax diseases and emerging economies. The market is Africa is not expected to grow that much because of low rate of anthrax diagnostic tests. Companies are facing challenge with their market expansion in Africa. Additionally, direct link with the customer is weaker in this region.
Launch of newer products, and strategic alliances are the key strategies adopted by market players
Global Anthrax Vaccine market further reveals that the key players increasingly adopting strategies such as launch of newer products, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In June 2019, a group of scientists claimed that they had developed a new vaccine against anthrax, which can generate immune response to both the anthrax toxin as well as its spores. Key player’s profiles in the report are Emergent BioSolutions (US), Elusys Therapeutics (US), Porton Biopharma Limited (UK), and Panacea Biotec (India). For More Information @ https://www.precisionbusinessinsights.com/market-reports/global-anthrax-vaccine-market/
Precision Business Insights (PBI) in its report titled “Global Anthrax Vaccine Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Detailed Segmentation
By Type
By End User
Geography
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)
About Us: Like it? Share it! More by this author |